We previously reported that patients with permanent neonatal diabetes mellitus (PNDM) due to proteotoxic MIDY mutations have fasting hyperglucagonemia [11], suggesting loss of insulin- mediated intra-islet suppression of glucagon production [24, 25]. Here, INS is linked to neonatal diabetes mellitus.